Jane Street
PASG icon

Jane Street’s Passage Bio PASG Stock Holding History

Jane Street’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,910
Closed -$44.3K – 10307
2024
Q4 		$44.3K Buy
3,910
+3,296
+537% +$42.9K ﹤0.01% 8999
2024
Q3 		$8.59K Buy
+614
New +$9.78K ﹤0.01% 9367
2023
Q2 		– Sell
-828
Closed -$15.9K – 9328
2023
Q1 		$15.9K Buy
828
+214
+35% +$5.8K ﹤0.01% 8686
2022
Q4 		$16.9K Sell
614
-272
-31% -$6.86K ﹤0.01% 8641
2022
Q3 		$22K Buy
+886
New +$34.9K ﹤0.01% 9181
2021
Q4 		– Sell
-570
Closed -$114K – 10630
2021
Q3 		$114K Buy
+570
New +$136K ﹤0.01% 9223
2020
Q4 		– Sell
-885
Closed -$232K – 7943
2020
Q3 		$232K Buy
885
+294
+50% +$101K ﹤0.01% 6247
2020
Q2 		$323K Buy
+591
New +$266K ﹤0.01% 5733

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's PASG Position: Q1 2025 in Review

Jane Street sold out of Passage Bio (PASG) in Q1 2025, closing a stake of 3,910 shares — an estimated $44.3K sold.

Jane Street first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $323K in Q2 2020. 41 funds tracked by Wall St. Rank hold PASG as of Q1 2025.

  • Jane Street reported no remaining Passage Bio position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 3,910 Passage Bio shares in Q1 2025, an estimated $44.3K.
  • Jane Street first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
  • Jane Street's Passage Bio position peaked at $323K in Q2 2020.
  • 41 funds tracked by Wall St. Rank held Passage Bio as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.